您现在的位置是:风核传媒 > 知识
Weight regain happens 4x faster after stopping GLP
风核传媒2026-02-01 02:25:23【知识】2人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(86415)
上一篇: ไฟป่าชัยนาท
相关文章
- 歌手李行亮自曝因抵制接不到工作 后悔参加《再见爱人》
- 宫崎英高称魂类游戏并非创新!只是设计理念满足玩家需求
- 科创50翻红 A股震荡回升
- 关于海南封关,你关心的疑问都有解答!|破谣局
- "สุดารัตน์" ขออาสารื้อระบบงบฯ 30 บาท หลังการรักษาจากระบบบัตรทองเริ่มวิกฤต
- 海峡杯厦门公开赛移动日格局生变 查喜洋洋领跑
- Giá vàng hôm nay 20.12.2025: Bật tăng sau hai ngày đứng yên
- “科技+服务”助力玉米、极地寒稻获丰收
- New York Times columnist omits details in fatal ICE shooting of Renee Good
- 勇者联盟炼狱守卫BOSS机制介绍
站长推荐
友情链接
- 《不正经的卡牌传说》PC版下载 Steam正版分流下载
- 意大利前总理贝卢斯科尼去世 终年86岁
- 深渊呼唤《事业归来》魔幻MU荣耀公测
- Nancy Pelosi says she didn't plan to tear up Trump State of the Union speech in 2020
- 安庆实施垃圾分类兑换奖品 积极吸引广大群众参与进来
- 英语演讲稿:青春励志英语演讲稿
- NVIDIA RTX 60系列显卡曝光:6090性能或提升30%
- 郑钦文正式宣布退出2026年澳网 身体恢复尚未达最佳竞技状态
- 市民反映分类垃圾箱不规范
- 女神联盟玩法技巧攻略
- 竞逐巅峰 2025劳力士中国青少年冠军锦标赛正式开杆 高尔夫球
- 浙江摧毁跨省特大走私集团 斩断伪装渔船背后的走私黑链
- 世界排名:沙佩尔夺冠进入前100 利什曼升至228位
- 2025年流泪想哭的歌词3条
- 首驱科技与潮流竞技IP《V26无畏巡回》达成深度合作,将联动线下体验店网络
- 长海路街道居民收到一份节日礼物——社区食堂今天开业,还能“饿了么”送餐到家
- 中国排名:郑蕴和攀升至491位 金博上升到1474位
- 京东:2025年终奖投入同比涨幅超70%,采销平均25薪
- 精选双色球专家:博文中头奖揽718万 阿旺中83万
- 日英大学新研究 游玩马里奥以及耀西系列缓解职业倦怠综合症






